{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:22:45Z","timestamp":1790392965444,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41375-020-0980-0","type":"journal-article","created":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T01:02:18Z","timestamp":1595206938000},"page":"747-751","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study"],"prefix":"10.1038","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9729-9974","authenticated-orcid":false,"given":"Michael Asger","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6220-9414","authenticated-orcid":false,"given":"Klaus","family":"Rostgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-5242","authenticated-orcid":false,"given":"Carsten Utoft","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hjalgrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,20]]},"reference":[{"key":"980_CR1","first-page":"1","volume":"3","author":"J Wang","year":"2014","unstructured":"Wang J, Khiabanian H, Rossi D, Fabbri G, Gattei V, Forconi F, et al. Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia. Elife. 2014;3:1\u201323.","journal-title":"Elife"},{"key":"980_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJMoa0806122","volume":"360","author":"O Landgren","year":"2009","unstructured":"Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360:659\u201367.","journal-title":"N Engl J Med"},{"key":"980_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/leu.2012.187","volume":"27","author":"J Moreira","year":"2013","unstructured":"Moreira J, Rabe KG, Cerhan JR, Kay NE, Wilson JW, Call TG, et al. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): A cohort study of newly diagnosed cases compared to controls. Leukemia. 2013;27:136\u201341.","journal-title":"Leukemia"},{"key":"980_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/j.1365-2141.2009.07849.x","volume":"147","author":"LA Anderson","year":"2009","unstructured":"Anderson LA, Landgren O, Engels EA. Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol. 2009;147:444\u20139.","journal-title":"Br J Haematol"},{"key":"980_CR5","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1365-2141.2007.06859.x","volume":"139","author":"O Landgren","year":"2007","unstructured":"Landgren O, Gridley G, Check D, Caporaso NE, Morris Brown L. Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol. 2007;139:791\u20138.","journal-title":"Br J Haematol"},{"key":"980_CR6","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1182\/blood-2006-08-044008","volume":"109","author":"O Landgren","year":"2007","unstructured":"Landgren O, Rapkin JS, Caporaso NE, Mellemkjaer L, Gridley G, Goldin LR, et al. Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood. 2007;109:2198\u2013201.","journal-title":"Blood"},{"key":"980_CR7","doi-asserted-by":"publisher","first-page":"E1158","DOI":"10.1002\/ijc.27626","volume":"131","author":"M-L Rasmussen","year":"2012","unstructured":"Rasmussen M-L, Hjalgrim H, M\u00f8lgaard-Nielsen D, Wohlfahrt J, Melbye M. Antibiotic use and risk of non-Hodgkin lymphomas. Int J Cancer. 2012;131:E1158\u201365.","journal-title":"Int J Cancer"},{"key":"980_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14175","volume":"8","author":"PJ Law","year":"2017","unstructured":"Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun. 2017;8:1\u201312.","journal-title":"Nat Commun"},{"key":"980_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-5573-5-7","volume":"5","author":"K Rostgaard","year":"2008","unstructured":"Rostgaard K. Methods for stratification of person-time and events\u2014a prerequisite for Poisson regression and SIR estimation. Epidemiol Perspect Innov. 2008;5:1\u201316.","journal-title":"Epidemiol Perspect Innov"},{"key":"980_CR10","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1182\/blood-2009-08-237651","volume":"114","author":"HT Tsai","year":"2009","unstructured":"Tsai HT, Caporaso NE, Kyle RA, Katzmann JA, Dispenzieri A, Hayes RB, et al. Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood. 2009;114:4928\u201332.","journal-title":"Blood"},{"key":"980_CR11","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/01.HS9.0000565996.51238.ae","volume":"3","author":"M Andersen","year":"2019","unstructured":"Andersen M, Grand M, Siersma V, Andersen C, Niemann C. Prediagnostic trajectories of hemoglobin, lymphocyte and platelet count in patients developing CLL. HemaSphere. 2019;3:853\u20134.","journal-title":"HemaSphere"},{"key":"980_CR12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1182\/asheducation-2005.1.231","volume":"2005","author":"S Poppema","year":"2005","unstructured":"Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematol Am Soc Hematol Educ Program. 2005;2005:231\u20138.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"980_CR13","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1182\/blood-2017-11-814608","volume":"131","author":"G Kleinstern","year":"2018","unstructured":"Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, et al. Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood. 2018;131:2541\u201351.","journal-title":"Blood"},{"key":"980_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1365-2141.2010.08339.x","volume":"151","author":"LR Goldin","year":"2010","unstructured":"Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, et al. Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol. 2010;151:152\u20138.","journal-title":"Br J Haematol"},{"key":"980_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0052808","volume":"7","author":"D Casabonne","year":"2012","unstructured":"Casabonne D, Almeida J, Nieto WG, Romero A, Fern\u00e1ndez-Navarro P, Rodriguez-Caballero A, et al. Common infectious agents and monoclonal B-cell lymphocytosis: a cross-sectional epidemiological study among healthy adults. PLoS One. 2012;7:1\u20138.","journal-title":"PLoS One"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0980-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0980-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0980-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:41:40Z","timestamp":1684618900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0980-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,20]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["980"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-0980-0","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,20]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"CUN received funding from the Danish Cancer Society and the Novo Nordisk Foundation (NNF16OC0019302), and received grants\/consultancy fees from AbbVie, Janssen, Gilead, AstraZeneca, Acerta, CSL Behring Roche and Novartis outside of this study. MAA, HH, and KR report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}